Home > Insider Trading > Filing (0001562180-24-002258)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1568651	Oscar Health Inc.	OSCR	Hospital & Medical Service Plans (6324)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1911946	Victoria Baltrus	75 Varick Street, 5Th Floor New York City NY 10013	Chief Accounting Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-03-01	4,121	$0.00	63,864	No	4	M	Direct
Class A Common Stock	Acquisiton	2024-03-01	4,811	$0.00	68,675	No	4	M	Direct
Class A Common Stock	Acquisiton	2024-03-01	7,500	$0.00	76,175	No	4	M	Direct
Class A Common Stock	Acquisiton	2024-03-01	75,643	$0.00	151,818	No	4	A	Direct
Class A Common Stock	Disposition	2024-03-04	33,707	$15.88	118,111	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Disposition	2024-03-01	4,121	$0.00	4,121	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2024-03-01	4,811	$0.00	4,811	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2024-03-01	7,500	$0.00	7,500	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,481	No	4	M	Direct
28,865	No	4	M	Direct
59,997	No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The Issuer previously granted the Reporting Person an award of 75,643 restricted stock units that vested on March 1, 2024, following the Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2022.
The restricted stock units vested with respect to 25% of the shares on September 1, 2022, and will vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2023.